# Health Catalyst to Participate in Upcoming Investor Conference
Canonical URL: https://biopharmsignal.com/news/HCAT/health-catalyst-to-participate-in-upcoming-investor-conference-70ce0f58
Ticker: HCAT
Company: Health Catalyst
Source: Health Catalyst
Published: 2026-06-16 20:05 EST
## Summary

Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a healthcare intelligence company designed to...

## Article Body
Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a healthcare intelligence company designed to accelerate measurable improvement for health systems, today announced that members of senior management will participate in the Truist Securities Healthcare Disruptors & Digital Health Conference, including a panel discussion titled “AI ROI in Healthcare: Real vs Hype Debate,” with Ben Albert, Chief Executive Officer, on Wednesday, June 24, 2026, at 3:30pm ET.

About Health Catalyst

Health Catalyst, Inc. (Nasdaq: HCAT) is a healthcare intelligence company that accelerates measurable improvement for health systems across cost, clinical, and consumer performance. Backed by deep domain expertise, proprietary AI-driven technology, and $2.8 billion in documented outcomes, Health Catalyst helps health systems move from data to confident, measurable action.

Health Catalyst Investor Relations Contact: Stephanie St. Clair Finance and Investor Relations, SVP +1 (855)-309-6800 ir@healthcatalyst.com

Health Catalyst Media Contact Kay Blazar VP, PR SVM PR & Marketing Healthcatalyst@SVMPR.com
## Recent Company News
- 2026-06-16 20:05 EST — [Health Catalyst to Participate in Upcoming Investor Conference](https://biopharmsignal.com/news/HCAT/health-catalyst-to-participate-in-upcoming-investor-conference-70ce0f58) — Source: Health Catalyst
- 2026-06-04 13:03 EST — [Health Catalyst to Divest Vitalware for $147 Million, Accelerating Strategic Transformation](https://biopharmsignal.com/news/HCAT/health-catalyst-to-divest-vitalware-for-147-million-accelerating-strategic-trans-3fdcad3f) — Source: Health Catalyst
- 2026-05-11 20:05 EST — [Health Catalyst Reports First Quarter 2026 Results](https://biopharmsignal.com/news/HCAT/health-catalyst-reports-first-quarter-2026-results-bc27d6b4) — Source: Health Catalyst
- 2026-05-01 12:00 EST — [Health Catalyst to Announce First Quarter 2026 Operating Results and Host Conference Call on Monday, May 11, 2026](https://biopharmsignal.com/news/HCAT/health-catalyst-to-announce-first-quarter-2026-operating-results-and-host-confer-a23ecc29) — Source: Health Catalyst
- 2026-04-30 13:27 EST — [Health Catalyst Appoints Steve Nelson, President of Aetna, to Its Board of Directors](https://biopharmsignal.com/news/HCAT/health-catalyst-appoints-steve-nelson-president-of-aetna-to-its-board-of-directo-59637695) — Source: Health Catalyst
## Related News
- 2026-07-28 20:15 EST — BDX — [BD Board Declares Dividend](https://biopharmsignal.com/news/BDX/bd-board-declares-dividend-ea66eb4a)
- 2026-07-28 13:00 EST — ENLV — [Enlivex Announces $400,000,000 Private Placement](https://biopharmsignal.com/news/ENLV/enlivex-announces-400-000-000-private-placement-20e71a7a)
- 2026-07-28 12:30 EST — XRAY — [Dentsply Sirona Advances Commercial Growth Strategy in Canada Through Expanded Medline Sinclair Relationship](https://biopharmsignal.com/news/XRAY/dentsply-sirona-advances-commercial-growth-strategy-in-canada-through-expanded-m-e2440bb2)
- 2026-07-28 12:30 EST — RLMD — [Relmada Therapeutics Appoints Uro-Oncology Leader Bipin Dalmia as Chief Business Officer](https://biopharmsignal.com/news/RLMD/relmada-therapeutics-appoints-uro-oncology-leader-bipin-dalmia-as-chief-business-5c4d7b11)
- 2026-07-28 12:05 EST — RIGL — [Rigel Announces Conference Call and Webcast to Report Second Quarter 2026 Financial Results](https://biopharmsignal.com/news/RIGL/rigel-announces-conference-call-and-webcast-to-report-second-quarter-2026-financ-5b987d7a)